Published in J Clin Microbiol on April 25, 2012
Comparison of five chromogenic media for recovery of vancomycin-resistant enterococci from fecal samples. J Clin Microbiol (2014) 0.85
Pseudo-outbreak of vancomycin-resistant-enterococcus (VRE) Colonization in a neonatal intensive care unit using spectra VRE surveillance medium. J Clin Microbiol (2012) 0.75
A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics. Clin Microbiol Rev (2017) 0.75
Evaluation of Spectra VRE, a new chromogenic agar medium designed to screen for vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Clin Microbiol (2010) 1.33
Novel chromogenic medium for detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. J Clin Microbiol (2008) 1.28
Evaluation of a new chromogenic medium, ChromID VRE, for detection of vancomycin-resistant Enterococci in stool samples and rectal swabs. J Clin Microbiol (2007) 1.26
Evaluation of a chromogenic agar under development to screen for VRE colonization. J Clin Microbiol (2010) 1.16
New selective and differential chromogenic agar medium, chromID VRE, for screening vancomycin-resistant Enterococcus species. J Microbiol Methods (2009) 1.14
Evaluation of BBL CHROMagar VanRE for detection of vancomycin-resistant Enterococci in rectal swab specimens. J Clin Microbiol (2010) 1.14
Comparison of performance of the novel chromogenic spectra VRE agar to that of bile esculin azide and Campylobacter agars for detection of vancomycin-resistant enterococci in fecal samples. J Clin Microbiol (2011) 1.11
Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabs. J Clin Microbiol (2008) 1.11
Comparison of two commercially available selective media to screen for vancomycin-resistant enterococci. Am J Clin Pathol (2002) 0.92
Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol (2011) 2.95
Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun (2005) 2.13
Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology (2013) 1.49
MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia. J Biol Chem (2005) 1.47
Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate? Urology (2013) 1.42
Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J Immunol (2009) 1.33
TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J Immunol (2008) 1.22
Vaccines for Chlamydia trachomatis infections. Curr Opin Investig Drugs (2002) 1.22
Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J Bacteriol (2007) 1.21
Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron. Infect Immun (2007) 1.20
Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge. Infect Immun (2002) 1.15
Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein. Vaccine (2009) 1.15
Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect Immun (2003) 1.10
Prediction of the membrane-spanning beta-strands of the major outer membrane protein of Chlamydia. Protein Sci (2002) 1.10
Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother (2012) 1.06
Interaction between components of the type III secretion system of Chlamydiaceae. J Bacteriol (2005) 1.06
Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide. J Infect Dis (2011) 1.04
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae. Int J Antimicrob Agents (2010) 0.99
New murine model for the study of Chlamydia trachomatis genitourinary tract infections in males. Infect Immun (2004) 0.98
Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy. J Clin Microbiol (2010) 0.98
Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion. J Antibiot (Tokyo) (2012) 0.93
Promoters for Chlamydia type III secretion genes show a differential response to DNA supercoiling that correlates with temporal expression pattern. J Bacteriol (2010) 0.92
Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. Infect Immun (2008) 0.92
Comparison of two commercially available selective media to screen for vancomycin-resistant enterococci. Am J Clin Pathol (2002) 0.92
Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection. Immunology (2006) 0.87
Comparison of broth enhancement to direct plating for screening of rectal cultures for ciprofloxacin-resistant Escherichia coli. J Clin Microbiol (2012) 0.84
Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice. Immunology (2003) 0.82
CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. J Clin Microbiol (2005) 0.81
Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis. Vaccine (2005) 0.78
Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae. Clin Diagn Lab Immunol (2002) 0.75
Microbiological sampling of the forgotten components of a flexible fiberoptic laryngoscope: what lessons can we learn? Otolaryngol Head Neck Surg (2013) 0.75
Protective effect of methicillin-susceptible Staphylococcus aureus carriage against methicillin-resistant S. aureus acquisition in nursing homes: a prospective cross-sectional study. Infect Control Hosp Epidemiol (2014) 0.75
Medical School Applicant Characteristics Associated With Performance in Multiple Mini-Interviews Versus Traditional Interviews: A Multi-Institutional Study. Acad Med (2017) 0.75